Bouzas E A, Freidlin V, Parry D M, Eldridge R, Kaiser-Kupfer M I
National Institutes of Health, Bethesda, Maryland 20892.
Br J Ophthalmol. 1993 Jun;77(6):354-7. doi: 10.1136/bjo.77.6.354.
This prospective study of 96 individuals from 29 families with neurofibromatosis 2, 49 of whom were affected, confirms in an extended series the previously reported association between posterior subcapsular/capsular cataract and neurofibromatosis 2. Posterior subcapsular/capsular cataracts were found in 36 (80%) of the 45 affected individuals (four individuals were excluded from statistical analyses). In addition, the association of peripheral cortical lens opacities with neurofibromatosis 2 was found to be statistically significant. Seventeen of the patients with neurofibromatosis 2 (37.8%) had peripheral cortical cataracts in comparison with none of the unaffected family members (p < 0.0001). In three patients peripheral cortical opacities were present despite the absence of posterior subcapsular/capsular cataracts. These findings support the inclusion of cortical cataracts of early onset, in addition to posterior subcapsular/capsular cataracts, in the diagnostic criteria of neurofibromatosis 2.
这项针对来自29个患有神经纤维瘤病2型家庭的96名个体的前瞻性研究(其中49人患病),在一个更大的样本系列中证实了先前报道的后囊下/囊膜性白内障与神经纤维瘤病2型之间的关联。在45名患病个体中,有36名(80%)发现了后囊下/囊膜性白内障(4名个体被排除在统计分析之外)。此外,发现周边皮质性晶状体混浊与神经纤维瘤病2型之间的关联具有统计学意义。2型神经纤维瘤病患者中有17名(37.8%)患有周边皮质性白内障,而未患病的家庭成员中无人患有(p < 0.0001)。在3名患者中,尽管没有后囊下/囊膜性白内障,但存在周边皮质性混浊。这些发现支持将早发性皮质性白内障以及后囊下/囊膜性白内障纳入神经纤维瘤病2型的诊断标准。